ScreenerHero
FREFresenius SE & Co. KGaA
XETRA · DE · Healthcare · Medical Care Facilities · fresenius.com
46.60EUR+0.83%Mkt Cap: 28.53B $P/E: 16.82

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fr…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG
$11.72BUSDP/E 12.1
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
EMEIS
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5
ADUS
Addus HomeCare Corporation
$2.24BUSDP/E 21.0

Key Statistics

Company
Market Cap28.53B $
Enterprise Value40.08B $
Revenue (TTM)25.31B $
Gross Profit6.19B $
Net Income (TTM)1.37B $
Revenue/Share44.93 USD
Last Price46.60 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees178.5K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINDE0005785604
Valuation
P/E (Trailing)16.82
P/E (Forward)11.69
PEG0.90
EV/EBITDA12.13
EV/Revenue1.58
P/S—
P/B1.32
EPS (TTM)2.77
EPS (Forward)3.96
52W Range
35.1164% of range52.96
52W High52.96 EUR
52W Low35.11 EUR
Profitability
Gross Margin24.89%
Oper. Margin10.63%
EBITDA Margin13.05%
Profit Margin5.53%
ROE6.62%
ROA3.05%
Growth
Revenue Growth5.20%
Earnings Growth17.20%
Cash Flow & Leverage
Operating CF2.80B $
CapEx (TTM)1.63B $
FCF Margin7.35%
FCF Yield6.52%
Net Debt11.02B $
Net Debt/EBITDA3.34
Balance Sheet
Debt/Equity0.62
Current Ratio1.28
Quick Ratio0.65
Book Value/Sh34.98 EUR
Cash/Share2.271 EUR
Dividends
Fwd Div Rate1.050 EUR
Trail. Div Rate1.050 EUR
Div. Yield2.27%
5Y Avg Yield1.15%
Payout Ratio37.91%
Ex-Div DateMay 25, 2026
Pay Date—
Splits
Last Split3:1
Split DateAug 4, 2014
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)55.86 EUR
Upside (mean)+19.9%
Target Range50.00 EUR – 63.50 EUR
€50.00+19.9% to mean€63.50
# Analysts13
Ownership
Shares Out.563.24M
Float410.56M
Insiders27.00%
Institutions43.95%
Technical
SMA 5043.00 (+8.4%)
SMA 20044.88 (+3.8%)
Beta0.83
S&P 52W Chg18.16%
Avg Vol (30d)873.66K
Avg Vol (10d)601.47K
Technical Indicators
RSI (14)60.3
MACD1.1681
MACD Signal1.3030
MACD Hist.-0.1349
BB Upper48.50 EUR
BB Middle45.68 EUR
BB Lower42.87 EUR
BB Width12.32%
ATR (14)0.9963 EUR
Vol Ratio (20d)0.76x